These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11038199)

  • 1. Is the new classification of neuroendocrine pancreatic tumors of clinical help?
    Schindl M; Kaczirek K; Kaserer K; Niederle B
    World J Surg; 2000 Nov; 24(11):1312-8. PubMed ID: 11038199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
    Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
    Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
    Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
    J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.
    Strosberg JR; Cheema A; Weber J; Han G; Coppola D; Kvols LK
    J Clin Oncol; 2011 Aug; 29(22):3044-9. PubMed ID: 21709192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?
    Ahrendt SA; Komorowski RA; Demeure MJ; Wilson SD; Pitt HA
    J Gastrointest Surg; 2002; 6(1):66-74. PubMed ID: 11986020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
    Haynes AB; Deshpande V; Ingkakul T; Vagefi PA; Szymonifka J; Thayer SP; Ferrone CR; Wargo JA; Warshaw AL; Fernández-del Castillo C
    Arch Surg; 2011 May; 146(5):534-8. PubMed ID: 21576607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience.
    Casadei R; Ricci C; Rega D; D'Ambra M; Pezzilli R; Tomassetti P; Campana D; Nori F; Minni F
    Pancreas; 2010 Aug; 39(6):825-8. PubMed ID: 20431423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
    van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
    Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
    Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of the pancreas.
    Varshney S; Johnson CD
    Indian J Gastroenterol; 2000; 19(4):181-3. PubMed ID: 11059186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience.
    Rojas Y; Warneke CL; Dhamne CA; Tsao K; Nuchtern JG; Lally KP; Vasudevan SA; Hayes-Jordan AA; Cass DL; Herzog CE; Hicks MJ; Kim ES; Austin MT
    J Pediatr Surg; 2012 Dec; 47(12):2199-204. PubMed ID: 23217876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in resected pancreatic neuroendocrine tumours: Experience in 95 patients.
    Sánchez-Bueno F; Rodríguez González JM; Torres Salmerón G; Bernabé Peñalver A; Balsalobre Salmeron M; de la Peña Moral J; Fuster Quiñonero M; Parrilla Paricio P
    Cir Esp; 2016 Oct; 94(8):473-80. PubMed ID: 27450270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
    Keutgen XM; Nilubol N; Kebebew E
    Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
    Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.